Tumor-interacting and Ag-presenting CD11cPOS DCs post-rIL12/sham treatment of our CT-2A-bearing mice were identified by PD-L1 and MHC-II markers, respectively (Figure 3H). This evidence concerns the gene CD274 and neoplasm.